达安基因

- 002030

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
达安基因(002030) 利润表
单位:万元
报表日期2023-12-312023-09-302023-06-302023-03-312022-12-31
一、营业总收入118,089.7184,233.6253,621.8434,103.811,204,613.50
营业收入118,089.7184,233.6253,621.8434,103.811,204,613.50
二、营业总成本113,344.0882,299.5355,421.0733,165.59519,146.83
营业成本58,492.9138,071.6825,252.8915,088.95327,153.53
营业税金及附加978.17460.03285.32126.485,828.64
销售费用17,283.3313,565.3910,247.085,316.9593,951.19
管理费用13,831.3414,063.309,785.356,161.5033,076.75
财务费用-7,474.89-6,133.33-5,340.38-1,169.06-11,103.64
研发费用30,233.2222,272.4515,190.817,640.7770,240.36
资产减值损失----------
公允价值变动收益43,569.0640,329.1647,996.022,357.428,232.14
投资收益-2,624.67-33.502,009.00-1,310.6827,118.39
其中:对联营企业和合营企业的投资收益-4,610.08-1,359.72690.06-1,593.8112,935.98
汇兑收益----------
三、营业利润12,162.1943,153.3948,910.025,052.30632,925.43
加:营业外收入188.96153.49149.395.7295.27
减:营业外支出997.55348.60328.2165.511,127.05
其中:非流动资产处置损失----------
四、利润总额11,353.5942,958.2948,731.204,992.52631,893.65
减:所得税费用4,180.448,347.988,891.931,214.7389,137.83
五、净利润7,173.1634,610.3139,839.273,777.79542,755.82
归属于母公司所有者的净利润10,465.9635,259.4440,275.543,656.14541,234.11
少数股东损益-3,292.80-649.13-436.27121.661,521.72
六、每股收益
基本每股收益(元/股)0.07460.25120.29000.02613.8565
稀释每股收益(元/股)0.07460.25120.29000.02613.8565
七、其他综合收益-86.7142.3340.09-36.96-284.15
八、综合收益总额7,086.4534,652.6439,879.373,740.83542,471.68
归属于母公司所有者的综合收益总额10,359.2435,284.2940,294.793,630.29540,899.26
归属于少数股东的综合收益总额-3,272.79-631.65-415.43110.541,572.42
下载全部历史数据到excel中 返回页顶